Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | LNMG |
---|---|---|
09:37 ET | 5000 | 0.315 |
02:03 ET | 10100 | 0.3 |
02:07 ET | 5000 | 0.3 |
02:09 ET | 12000 | 0.315 |
03:55 ET | 42500 | 0.295 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Linike Medical Group Ltd | 210.7M | -2.7x | --- |
Keen Vision Acquisition Corp | 210.5M | 32.4x | --- |
Newbury Street II Acquisition Corp | 209.3M | 0.0x | --- |
Japan Smaller Capitalization Fund | 213.9M | --- | --- |
Investcorp Europe Acquisition Corp I | 207.5M | 47.5x | --- |
Lazard Global Total Return and Income Fund Inc | 214.6M | --- | --- |
Linike Medical Group Ltd. is specialized in the research and development (R&D), production and sales of large-scale external beam therapy equipment-medical electron linear accelerator, used for treating cancers. The Company’s subsidiaries include China Linike Medical Group Ltd and Sichuan Huarong Zhengtai Medical Technology Co., Ltd.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $210.7M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 668.9M |
Linike Medical Group Ltd does not pay a dividend. | |
Beta | --- |
EPS | $-0.11 |
Book Value | $-0.14 |
P/E Ratio | -2.7x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.